Company News

Allergan’s Eyelash Drug Gets Good News from FDA

Once-a-day treatment enhances lashes.

Author Image

By: TOM BRANNA

Editor

Shares of cosmetic drugmaker Allergan climbed Monday on news that a panel of government advisers favorably reviewed the company’s experimental drug to enhance eyelashes. Allergan, which makes Botox anti-wrinkle injections, has asked the Food and Drug Administration to approve its Lumigan formula to enhance eyelashes for patients 18 and older. The drug is designed to be applied once daily to the base of the lashes. On Friday a Food and Drug Administration panel of experts voted unanimousl...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters